| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +57% |
| 3Y CAGR | -11% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +1,000% |
| 3Y CAGR | -18% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,688.90 -65.80 (1.75%) | 17,211.67 | 23.41 | 4.1 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,249.10 +27.50 (1.24%) | 16,883.72 | 24.9 | 5.01 | ||
Natco PharmaNATCOPHARM | ₹785.15 +0.70 (0.09%) | 15,397.22 | 13.45 | 1.47 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,101.00 +21.50 (0.35%) | 15,192.25 | 89.56 | 17.41 |